Angiochem Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

Angiochem's estimated annual revenue is currently $1.9M per year.(i)
Angiochem's estimated revenue per employee is $155,000

Employee Data

Angiochem has 12 Employees.(i)
Angiochem grew their employee count by -8% last year.

Angiochem's People

Name	Title	Email/Phone
1 Betty Lawrence	VP Development	Reveal Email/Phone
2 John Huss	Executive Chairman	Reveal Email/Phone

Angiochem Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	27	-7%	N/A	N/A
#10 MSBiotec	$10.1M	65	5%	N/A	N/A

Add Company

Show More Biotech Companies

What Is Angiochem?

Angiochem is a clinical-stage biotechnology company discovering and developing novel drugs that are crossing the blood-brain barrier to treat brain diseases. These new Engineered Peptide Compounds (EPiC) have the potential to address significant medical needs, many of which cannot be effectively addressed due to the fundamental physiological challenge the blood-brain barrier presents for therapeutic intervention. Angiochem is developing a deep and broad product pipeline, including small and large molecules, for the treatment of a wide range of brain diseases including brain cancers, lysosomal storage disorders, pain and others. The EPiC platform has been strongly validated in humans.

keywords:N/A

N/A

Total Funding

Number of Employees

$1.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator